Cardiac and vascular toxicity of amivantamab in non-small cell lung cancer (NSCLC): A systematic review

Maria Gavriatopoulou, M.D. M.Sc. Ph.D. Medical Oncologist and Assistant Professor at the Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital. Certified in Clinical Trials at the Department of Clinical Research and Medical Education, National Institutes of Health (NIH), and at the Department of Epidemiology, Johns Hopkins University

Comments (0)

No login
gif